Zimvie Inc (ZIMV) Quarterly and Annual Segment Results by Country and Region - CSIMarket
CSIMarket
 
Zimvie Inc   (NASDAQ: ZIMV)

Select the Financial Report: Select the Period:


Description of Zimvie Inc's Business Segments


ZimVie Inc. is a medical technology company that specializes in providing innovative solutions primarily focused on musculoskeletal healthcare. The company emerged from the spin-off of the dental and spine divisions from Zimmer Biomet, positioning itself to offer a range of products and services catering to the orthopedic and dental markets. Here is a comprehensive overview of the segments, products, and services offered by ZimVie Inc.

Segments

1. Orthopedic: ZimVie’s orthopedic segment primarily focuses on developing and distributing products related to spine and joint health. This segment is crucial as it addresses the growing global need for orthopedic surgeries due to an aging population and an increase in sports-related injuries.

2. Dental: The dental segment is dedicated to advancing oral health through innovative solutions for dental professionals. This segment is essential for providing products that support restorative dentistry, implantology, and digital dentistry.

Products and Services

1. Orthopedic Products

- Spine Products:
- Implants: Fusion and non-fusion devices designed for various spinal disorders. These include interbody fusion devices, pedicle screws, rods, and cervical plates aimed at stabilizing spinal structures.
- Surgical Instruments: Tools and instrumentation for spinal surgeries that enhance surgical efficiency and patient safety.
- Biologics: These products promote healing and regeneration in spinal fusion procedures. They often include bone graft substitutes or growth factors.

- Joint Reconstruction:
- Knee Implants: Products designed for total and partial knee replacements. They focus on biocompatibility and patient-specific solutions to improve outcomes.
- Hip Implants: Include both cemented and cementless total hip arthroplasty systems that are designed for durability and long-term performance.
- Shoulder Implants: Systems that address shoulder pathologies, offering both anatomic and reverse total shoulder arthroplasties.

Dental Products

- Dental Implants: ZimVie produces a range of dental implants designed for stability and longevity. These are aimed at both restorative and aesthetic dental procedures.
- Prosthetics: The company offers prosthetic solutions for creating custom dental restorations, including crowns, bridges, and overdentures.
- Surgical Products: Instruments and materials designed for oral and maxillofacial surgeries, improving the efficiency and precision of surgical procedures.

Digital Solutions

- ZimVie provides integrated digital solutions that enhance treatment workflows in both orthopedic and dental settings. This includes:
- Imaging Systems: Advanced imaging technologies that support surgical planning and precision during procedures.
- Software Solutions: Platforms for designing custom implants or prosthetics, streamlining the manufacturing process, and enhancing the patient experience.

Services

- Education and Training: ZimVie invests in providing educational resources and training programs for healthcare professionals. This ensures that orthopedic surgeons and dental practitioners are up-to-date with the latest techniques and technologies.
- Patient Support: The company offers services aimed at patient education, surgical navigation systems, and postoperative care, aiming to improve patient outcomes and satisfaction.
- R&D Collaborations: ZimVie is involved in research collaborations to innovate new technologies and products within the musculoskeletal and dental healthcare space.

Summary

ZimVie Inc. operates with a clear focus on innovative musculoskeletal solutions across its orthopedic and dental segments. By providing a wide array of products and services, including advanced surgical technologies, biologics, digital solutions, and dedicated education, ZimVie aims to enhance surgical outcomes and improve the quality of life for patients. The company continues to adapt to the changing dynamics of the healthcare environment, striving to meet the needs of healthcare providers and patients alike.


Composition of Zimvie Inc Revenues by Segments

 
U S    58.25 % of total Revenue
Spain    11.88 % of total Revenue
Other countries    29.87 % of total Revenue

Q2 three months ended (Jun 30 2025)
Revenues by Business Segments Revenues
(in millions $)
%
(of total Revenues)
U S 67.96 58.25 %
Spain 13.86 11.88 %
Other countries 34.85 29.87 %
Total 116.66 100 %




Q2 three months ended (Jun 30 2025)
Revenue Growth rates by Segment Y/Y Revenue
%
Q/Q Revenue
%
U S -1.96 % 3.23 %
Spain 8.07 % 1.76 %
Other countries 0.5 % 7.07 %
Total -0.13 % 4.17 %




Q2 three months ended (Jun 30 2025)
Income by Business Segments Income
(in millions $)
%
(Profit Margin)
Total -3.95 -




Q2 three months ended (Jun 30 2025)
Income Growth rates by Segment Y/Y Income
%
Q/Q Income
%
Total - -




Annual Report on Zimvie Inc Divisions, Sales by Country

 
U S   U S Segment contribution to total sales 59.33 % of total Revenue
Spain   Spain Segment contribution to total sales 11.12 % of total Revenue
Other countries   Other countries Segment contribution to total sales 29.55 % of total Revenue


Twelve months ended 2024
ZIMV s Annual Revenue by Geography and Business Segments Sales
(in millions $)
%
(of total Sales)
U S 266.82 59.33 %
Spain 50.03 11.12 %
Other countries 132.90 29.55 %
Total 449.75 100 %


Twelve months ended 2024
ZIMV s Annual Income by Country and Business Segments Income
(in millions $)
%
(Profit Margin)
Total -25.83 -

Twelve months ended 2024
Annual Revenue and Income Growth by Country and Business Segments % Y/Y Sales Growth % Y/Y Income Growth
U S -1.02 % -
Spain -1.95 % -
Other countries -2.72 % -
Total -1.68 % -



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.